| Overview |
| bsm-61867r-100ul |
| ILF2 Monoclonal Antibody |
| WB, FCM, IHC-P, IHC-F, IP, IF |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| KLH conjugated synthetic peptide derived from human ILF2 |
| Monoclonal |
| Recombinant |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| 10mM phosphate buffered saline(pH 7.4) with 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol. |
| Shipped at 4°. Store at -20°C for one year. Avoid repeated freeze/thaw cycles. |
| Target |
| 3608 |
| Q12905 |
| Nucleus |
| ILF 2; MGC8391; NF45. |
| Appears to function predominantly as a heterodimeric complex with ILF3. This complex may regulate transcription of the IL2 gene during T-cell activation. It can also promote the formation of stable DNA-dependent protein kinase holoenzyme complexes on DNA. |
| Application Dilution |
| WB |
:1:1000-1:2000 |
| FCM |
FCM:1:20-1:100 |
| IHC-P |
IHC-P:1:100-1:200 |
| IHC-F |
IHC-F:1:100-1:200 |
| IP |
IP:1:20-1:50 |
| IF |
IF:1:100-1:200 |
Powered by Bioz